This test utilizes multiparametric flow cytometry to identify and characterize plasma cells in bone marrow, peripheral blood, or tissue samples. CD138 (Syndecan-1) is used as the primary marker to gate plasma cells, which are further analyzed with a panel of additional markers including CD38, CD19, CD45, CD56, CD117, and surface light chains (kappa/lambda).